Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor

Clinical trial NCT00069940 · COMPLETED

Trial details

NCT number: NCT00069940
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Gastrointestinal Stromal Tumor Sarcoma

Start date: 2000-12-01
Primary completion: 2006-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.